相关实验视频
Updated: May 6, 2026

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
25.7K
嗅觉功能障碍作为神经退行性疾病中早期淋巴失败的临床标志物
Gonzalo Sánchez-Benavides1,2,3, Alex Iranzo4,5,6, Oriol Grau-Rivera1,2,3
1Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, 08005 Barcelona, Spain.
Diagnostics (Basel, Switzerland)
|March 28, 2025
概括
嗅觉功能障碍 (OD) 可能在神经退行性疾病中标志着早期淋巴系统衰竭. 这是由于嗅觉结构中蛋白质的异常积累造成的,这可能与衰老和荷尔蒙变化有关.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 病理学 病理学 病理学
背景情况:
- 错误折叠的蛋白质积累是神经退行性疾病的核心.
- 嗅觉功能障碍 (OD) 在衰老中普遍存在,并且在阿尔茨海默氏症/帕金森症症状之前出现.
- 嗅觉通路中的早期蛋白质聚合物有助于OD.
研究的目的:
- 研究嗅觉功能障碍作为早期淋巴系统功能障碍的潜在临床标志物.
- 探索病态蛋白质积累在嗅觉结构中的作用.
- 为了检查与雌激素损失相关的淋巴清除的潜在基于性别的差异.
主要方法:
- 审查有关蛋白质聚合,嗅觉通路和淋巴系统功能的现有文献.
- 分析鼻道在脑脊液和溶液外流中的作用.
- 考虑激素影响 (雌激素损失) 对淋巴清除机制的考虑.
主要成果:
- 淋巴系统的功能随着年龄的增长而下降,并且在神经退行性疾病中受损.
- 鼻腔通道是脑脊液和溶液的主要出口.
- 雌激素的损失可能会加剧临近更年期和更年期后妇女的淋巴功能障碍.
结论:
- 嗅觉功能障碍可能是淋巴系统衰竭的早期临床指标.
- 嗅觉结构中的异常蛋白质积累可能是奥迪的基础,并反映了废物清理功能受损.
- 需要进一步的研究来确认OD作为神经退行症中淋巴功能障碍的可靠代理.
相关概念视频
Olfaction
40.5K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
40.5K
Olfactory Receptors: Location and Structure
10.6K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
10.6K
Physiology of Smell and Olfactory Pathway
13.2K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
13.2K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Alzheimer Disease ll: Pathophysiology
44
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
44

